Deprecated: wp_make_content_images_responsive is deprecated since version 5.5.0! Use wp_filter_content_tags() instead. in /home/fedrigon/public_html/wp-includes/functions.php on line 5325
Medical cannabis, especially in higher THC doses, has been approved for use in the United Kingdom and Germany plus 24 other European countries for conditions including but not limited to chronic pain, Spinal cord treatment, Anxiety, HIV/AIDS Appitite loss, Multiple Sclerosis, Crohn’s disease, PTSD, Chemotherapy side effects, Glaucoma, Anorexia, Lennox- Gastaut syndrome, Alzheimer’s, Dravet syndrome, Tourette’s syndrome, Intractable spasticity and Cachexia.
Hellenic Dynamics strongly believes that controlling every aspect of the cultivation cycle of medical cannabis flowers is the best way to maximize the benefit of this medicine to patients. Specific cannabis genetics have also been shown to have differing effects against certain pain indicators. To address this issue, Hellenic Dynamics has formed several partnerships to begin research and development studies of our genetics in order to conduct efficacy trials against pain indictors in patients. This will allow Hellenic Dynamics to be at the forefront of the next evolution of the medical cannabis industry by way of registering certain strains at the E.U. level to produce IP protected genetics.